https://www.selleckchem.com/pr....oducts/ginsenoside-r
10, 0.27] for sestamibi to 70% [0.59, 0.79] for FCH PET. Conclusion In this prospective study using blinded readers, the CLR for FCH was 75%. In patients with paired sestamibi, the use of FCH PET increased the CLR from 17% to 70%. FCH PET is a superior imaging modality for the localization of parathyroid adenomas.Hepatocyte transporters control the hepatobiliary elimination of many drugs, metabolites and endogenous substances. Hepatocyte transporter function is altered in several pathophysiological situations and can be modulate